222 related articles for article (PubMed ID: 31341258)
1. Leflunomide increased the renal exposure of acyclovir by inhibiting OAT1/3 and MRP2.
Liao XY; Deng QQ; Han L; Wu ZT; Peng ZL; Xie Y; Wang GJ; Aa JY; Pan GY
Acta Pharmacol Sin; 2020 Jan; 41(1):129-137. PubMed ID: 31341258
[TBL] [Abstract][Full Text] [Related]
2. Interaction of immunosuppressive drugs with human organic anion transporter (OAT) 1 and OAT3, and multidrug resistance-associated protein (MRP) 2 and MRP4.
El-Sheikh AA; Greupink R; Wortelboer HM; van den Heuvel JJ; Schreurs M; Koenderink JB; Masereeuw R; Russel FG
Transl Res; 2013 Dec; 162(6):398-409. PubMed ID: 24036158
[TBL] [Abstract][Full Text] [Related]
3. Benzylpenicillin inhibits the renal excretion of acyclovir by OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Sun H; Peng J; Ma X; Liu K
Pharmacol Rep; 2013; 65(2):505-12. PubMed ID: 23744435
[TBL] [Abstract][Full Text] [Related]
4. Influence of organic anion transporter 1/3 on the pharmacokinetics and renal excretion of ginkgolides and bilobalide.
Yaro P; Nie J; Xu M; Zeng K; He H; Yao J; Wang R; Zeng S
J Ethnopharmacol; 2019 Oct; 243():112098. PubMed ID: 31325605
[TBL] [Abstract][Full Text] [Related]
5. Inhibitory effect of JBP485 on renal excretion of acyclovir by the inhibition of OAT1 and OAT3.
Ye J; Liu Q; Wang C; Meng Q; Peng J; Sun H; Kaku T; Liu K
Eur J Pharm Sci; 2012 Sep; 47(2):341-6. PubMed ID: 22728397
[TBL] [Abstract][Full Text] [Related]
6. Apigenin, a novel candidate involving herb-drug interaction (HDI), interacts with organic anion transporter 1 (OAT1).
Wu T; Li H; Chen J; Cao Y; Fu W; Zhou P; Pang J
Pharmacol Rep; 2017 Dec; 69(6):1254-1262. PubMed ID: 29128807
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of p-aminohippurate and probenecid on the renal clearance of adefovir and benzylpenicillin as probe drugs for organic anion transporter (OAT) 1 and OAT3 in humans.
Maeda K; Tian Y; Fujita T; Ikeda Y; Kumagai Y; Kondo T; Tanabe K; Nakayama H; Horita S; Kusuhara H; Sugiyama Y
Eur J Pharm Sci; 2014 Aug; 59():94-103. PubMed ID: 24747579
[TBL] [Abstract][Full Text] [Related]
8. Organic anion transporters involved in the excretion of bestatin in the kidney.
Zhu Y; Meng Q; Wang C; Liu Q; Sun H; Kaku T; Liu K
Peptides; 2012 Feb; 33(2):265-71. PubMed ID: 22273603
[TBL] [Abstract][Full Text] [Related]
9. Leflunomide Increases Hepatic Exposure to Methotrexate and Its Metabolite by Differentially Regulating Multidrug Resistance-Associated Protein Mrp2/3/4 Transporters via Peroxisome Proliferator-Activated Receptor
Wang L; Ma L; Lin Y; Liu X; Xiao L; Zhang Y; Xu Y; Zhou H; Pan G
Mol Pharmacol; 2018 Jun; 93(6):563-574. PubMed ID: 29618584
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Prediction of Human Renal Clearance and Drug-Drug Interactions of Organic Anion Transporter Substrates Using In Vitro Transport Data: A Relative Activity Factor Approach.
Mathialagan S; Piotrowski MA; Tess DA; Feng B; Litchfield J; Varma MV
Drug Metab Dispos; 2017 Apr; 45(4):409-417. PubMed ID: 28179375
[TBL] [Abstract][Full Text] [Related]
11. Effects of 1α,25-dihydroxyvitamin D3 , the natural vitamin D receptor ligand, on the pharmacokinetics of cefdinir and cefadroxil, organic anion transporter substrates, in rat.
Kim YC; Kim IB; Noh CK; Quach HP; Yoon IS; Chow ECY; Kim M; Jin HE; Cho KH; Chung SJ; Pang KS; Maeng HJ
J Pharm Sci; 2014 Nov; 103(11):3793-3805. PubMed ID: 25266751
[TBL] [Abstract][Full Text] [Related]
12. Coadministration of vindesine with high-dose methotrexate therapy increases acute kidney injury via BCRP, MRP2, and OAT1/OAT3.
Huang C; Xia F; Xue L; Liu L; Bian Y; Jin Z; Miao L
Cancer Chemother Pharmacol; 2020 Feb; 85(2):433-441. PubMed ID: 31691080
[TBL] [Abstract][Full Text] [Related]
13. The inhibition mechanism of the uptake of lamivudine via human organic anion transporter 1 by Stellera chamaejasme L. extracts.
Pan LY; Zeng K; Li L; Lou Y; Zeng S
Chin J Nat Med; 2019 Sep; 17(9):682-689. PubMed ID: 31526503
[TBL] [Abstract][Full Text] [Related]
14. Sulfate conjugating and transport functions of MDCK distal tubular cells.
Ng KH; Lim BG; Wong KP
Kidney Int; 2003 Mar; 63(3):976-86. PubMed ID: 12631078
[TBL] [Abstract][Full Text] [Related]
15. Prediction of renal transporter-mediated drug-drug interactions for a drug which is an OAT substrate and inhibitor using PBPK modelling.
Ball K; Jamier T; Parmentier Y; Denizot C; Mallier A; Chenel M
Eur J Pharm Sci; 2017 Aug; 106():122-132. PubMed ID: 28552429
[TBL] [Abstract][Full Text] [Related]
16. Contribution of multidrug resistance protein 2 (MRP2/ABCC2) to the renal excretion of p-aminohippurate (PAH) and identification of MRP4 (ABCC4) as a novel PAH transporter.
Smeets PH; van Aubel RA; Wouterse AC; van den Heuvel JJ; Russel FG
J Am Soc Nephrol; 2004 Nov; 15(11):2828-35. PubMed ID: 15504935
[TBL] [Abstract][Full Text] [Related]
17. Investigation of Endogenous Compounds Applicable to Drug-Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans.
Tsuruya Y; Kato K; Sano Y; Imamura Y; Maeda K; Kumagai Y; Sugiyama Y; Kusuhara H
Drug Metab Dispos; 2016 Dec; 44(12):1925-1933. PubMed ID: 27638508
[TBL] [Abstract][Full Text] [Related]
18. [Tubular transporters OAT1 and MRP2 and clearance of adefovir].
Servais A; Lechat P; Zahr N; Urien S; Aymard G; Jaudon MC; Deray G; Isnard Bagnis C
Nephrol Ther; 2005 Nov; 1(5):296-300. PubMed ID: 16895698
[TBL] [Abstract][Full Text] [Related]
19. Drugs interacting with organic anion transporter-1 affect uptake of Tc-99m-mercaptoacetyl-triglycine (MAG3) in the human kidney: therapeutic drug interaction in Tc-99m-MAG3 diagnosis of renal function and possible application of Tc-99m-MAG3 for drug development.
Takahara N; Saga T; Inubushi M; Kusuhara H; Seki C; Ito S; Oyama N; Yokoyama O; Sugiyama Y; Fujibayashi Y
Nucl Med Biol; 2013 Jul; 40(5):643-50. PubMed ID: 23618840
[TBL] [Abstract][Full Text] [Related]
20. Aspirin and probenecid inhibit organic anion transporter 3-mediated renal uptake of cilostazol and probenecid induces metabolism of cilostazol in the rat.
Wang C; Wang C; Liu Q; Meng Q; Cang J; Sun H; Peng J; Ma X; Huo X; Liu K
Drug Metab Dispos; 2014 Jun; 42(6):996-1007. PubMed ID: 24692216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
